	Pancreatic cancer immunotherapy biomarkers: from traditional markers to multimodal integration and dynamic monitoring. Front Immunol Zhao WY, Zhao JW. PMID: 41939911 [PubMed - indexed for MEDLINE]
	Correction: Vimentin expression as a prognostic marker in pancreatic cancer: a systematic review and meta-analysis. Front Med (Lausanne) Cretu OI, Lungulescu CV, Gentiluomo M, Turcu-Stiolica A, Pani, Patrascu S, Ungureanu BS. PMID: 41939785 [PubMed]
	Radiotherapy as a partner for immunotherapy in pancreatic cancer: current landscape and future directions. Front Oncol Diao Z, Wang Y, Mu S, Wu X, Yu S, Wang Z. PMID: 41939454 [PubMed]
	Beyond conventional biomarkers: the role of alpha-fetoprotein in gastroenteropancreatic neuroendocrine neoplasms. Front Endocrinol (Lausanne) La Salvia A, Fanciulli G. PMID: 41938105 [PubMed - indexed for MEDLINE]
	Impact of Male Sex and Umbilical-Pancreatic Anatomy on Surgical Difficulty in Minimally Invasive Distal Pancreatectomy: A Propensity-Matched Analysis. Asian J Endosc Surg Fukada M, Mitsui N, Horaguchi T, Yasufuku I, Sato Y, Tajima JY, Tanaka Y, Matsuhashi N. PMID: 41936535 [PubMed - indexed for MEDLINE]
	Unmasking FCGR2B as a high-grade serous ovarian cancer specific marker of immune suppression and tumor progression through multi-omics mining. Transl Oncol Zhou J, Zeng T, Ye M, Li M, Wen L, Liu X, Zhang Z, Meng Y. PMID: 41934917 [PubMed - as supplied by publisher]
	Lipid signaling networks in pancreatic cancer progression and therapeutic perspectives. Trends Endocrinol Metab Costamagna A, Milan G, De Santis MC, Carrer A, Martini M. PMID: 41933959 [PubMed - as supplied by publisher]
	Tumor Evolution in an Ecological Context: How Genetic and Microenvironmental Factors Shape the Pathogenesis of Pancreatic Cancer. Crit Rev Oncol Hematol Girolimetti G, Bramato G, Fiore A, Romano R, Guerra F, Bucci C, Basset A. PMID: 41933855 [PubMed - as supplied by publisher]
	Demographic and Prognostic Significance of Surgically-Treated Intrathyroidal Thymic Carcinoma: A Systematic Review and Meta-Analysis. World J Surg Jenkins CR, Hajibandeh S, Hajibandeh S, Scott-Coombes DM, Egan RJ. PMID: 41931541 [PubMed - as supplied by publisher]
	Integrating liquid biopsies and artificial intelligence for early cancer detection: A systematic review and meta-analysis. Eur J Cancer Filis P, Markozannes G, Salgkamis D, Tsiknakis N, Zerdes I, Pagkalidou E, Manou M, Filis N, Papakonstantinou A, Mavroudis D, Matikas A, Tsilidis KK, Foukakis T. PMID: 41930854 [PubMed - as supplied by publisher]
	Emerging Chimeric Antigen Receptor-Immune Cell Therapy for Pancreatic Cancer: Mechanisms, Clinical Advances, and Future Perspectives. Oncol Res Wang S, Wang M, Yao W. PMID: 41930147 [PubMed - indexed for MEDLINE]
	Presentation, Treatment, and Outcomes of Non-bacterial Thrombotic Endocarditis in Pancreatic Cancer: A Systematic Review. Cureus Hussain F, Huba M, Paracha A, Kwait B, Siddiqui Z, Patel H, Lee A, Patel H, Palati S, Papale A, Copeland-Halperin RS, King D. PMID: 41930062 [PubMed]
	Overcoming multidimensional immunotherapy resistance in PDAC: from microenvironment to clinic. Front Immunol Yan J, Ou H, Wang S, Jin K, Yu X, Wu W. PMID: 41929491 [PubMed - indexed for MEDLINE]
	Automated Extraction of Cancer Registry Data from Pathology Reports: Comparing LLM-Based and Ontology-Driven NLP Platforms. medRxiv McPhaul T, Kreimeyer K, Baras A, Botsis T. PMID: 41929331 [PubMed]
	Osteopontin in pancreatic cancer: A systematic review. Med Int (Lond) Weber GF. PMID: 41928921 [PubMed]
	Systematic review and meta-analysis comparing postoperative and oncological outcomes between local excision plus radiotherapy versus total mesorectal excision for rectal cancer. World J Surg Oncol Kitaguchi D, Forgione A, Innocenzi C, Yang Y, Espínola F, Giménez M, Oda T, Marescaux J. PMID: 41928271 [PubMed - as supplied by publisher]
	Interpretation of constitutional cancer predisposition gene variants in 14â€ˆ765 individuals in the 100â€ˆ000 Genomes Project cancer arm: a retrospective cohort analysis. Lancet Oncol Whitworth J, Wang VY, Black D, Davies HR, Degasperi A, Prepelita D, Nik-Zainal S. PMID: 41926963 [PubMed - indexed for MEDLINE]
	[(177)Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study. Lancet Oncol Sandhu S, Joshua AM, Emmett L, Bressel M, Anton A, Spain L, Horvath LG, Pasam A, Tolmeijer SH, Akhurst TJ, Alipour R, Banks P, Buteau JP, Cassidy E, Crumbaker M, Dhiantravan N, Xu W, Chan J, Hitchen N, Scalzo M, Ravi Kumar AS, Kong G, Wallace R, Williams N, Williams S, Haynes NM, Neeson P, Wyatt AW, Hicks RJ, Hofman MS. PMID: 41926961 [PubMed - indexed for MEDLINE]
	Oxaliplatin-induced peripheral neuropathy in cancer treatment: Mechanisms, risk factors, and management strategies. Adv Clin Exp Med Pigo, Banach M, Walkowiak PS, Zygulska A. PMID: 41926777 [PubMed - as supplied by publisher]
	Reply to: "Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology," "Key Methodological Considerations in the Interpretation of the CONKO-007 Trial," and "Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer". J Clin Oncol Fietkau R, Semrau S, Kallies A, Adler W, Oettle H. PMID: 41926724 [PubMed - as supplied by publisher]

Articles 1 - 20 / 59618

Page 1 of 2981



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy